Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA's Risk Communications On Public Health Threats To Be Tested

Executive Summary

Agency-sponsored focus groups will assess information about medical countermeasures; project builds on previous FDA efforts to understand consumer perceptions of risk communications.


Related Content

Umbrella Branding Is ‘Particular Concern’ As FDA Requests Research Proposals